SomnoMed Limited (ASX:SOM)
0.3350
+0.0050 (1.52%)
Aug 28, 2026, 4:10 PM AEST
SomnoMed Revenue
In the fiscal year ending June 30, 2026, SomnoMed had annual revenue of 114.53M AUD with 2.73% growth. SomnoMed had revenue of 60.72M in the half year ending December 31, 2025, with 34.58% growth.
Revenue
114.53M
Revenue Growth
+2.73%
P/S Ratio
0.63
Revenue / Employee
381.77K
Employees
300
Market Cap
72.30M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 114.53M | 3.04M | 2.73% |
| Jun 30, 2025 | 111.49M | 19.84M | 21.65% |
| Jun 30, 2024 | 91.65M | 8.03M | 9.61% |
| Jun 30, 2023 | 83.62M | 11.04M | 15.20% |
| Jun 30, 2022 | 72.58M | 9.87M | 15.75% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Saluda Medical | 114.04M |
| Compumedics | 61.88M |
| Nova Eye Medical | 34.87M |
| Cyclopharm | 34.42M |
| CleanSpace Holdings | 20.66M |
| Lumos Diagnostics Holdings | 19.07M |
| EMVision Medical Devices | 8.36M |
| OncoSil Medical | 3.72M |
SomnoMed News
- 6 months ago - SomnoMed Earnings Call Transcript: H1 2026 - Transcripts
- 6 months ago - SomnoMed Quarterly report: H1 2026 - Filings
- 6 months ago - SomnoMed Slides: H1 2026 - Filings
- 6 months ago - SomnoMed Earnings release: H1 2026 - Filings
- 9 months ago - SomnoMed Slides: FY 2025 - Filings
- 10 months ago - SomnoMed Earnings release: Q1 2026 - Filings
- 11 months ago - SomnoMed Slides: Investor Presentation - Filings
- 1 year ago - SomnoMed Earnings Call Transcript: H2 2025 - Transcripts